Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin
NCT02082028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 241
Last updated 2017-05-03
Summary
To demonstrate the superiority of a chronic care model (SINERGIA model) supported by the Self Monitoring of Blood Glucose with BGStar over usual care in improving glycemic control at 12 months in patients with type 2 diabetes not treated with insulin.
Conditions
Interventions
- DEVICE
-
BGStar
- DEVICE
-
glucose meter
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Science & Operations · Sanofi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-27
- Primary Completion
- 2015-07-30
- Completion
- 2015-07-30
Countries
- Italy
Study Locations
More Related Trials
-
A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia
NCT01407289 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Insulin Lispro Mix 50/50 Therapy
NCT01303042 ·Status: UNKNOWN ·Phase: NA
-
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
NCT00976391 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients With Type 2 Diabetes Mellitus
NCT01435616 ·Status: COMPLETED ·Phase: PHASE3
-
Lispro Mix 25 vs. Glargine in Type 2 Diabetics
NCT00551356 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
NCT05662332 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glargine in Type 1 Diabetes Mellitus
NCT00272090 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
NCT06107153 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
NCT02086227 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
NCT01212913 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
NCT04932928 ·Status: RECRUITING ·Phase: NA
-
20 Week Bridging Study in Type II DM
NCT00563225 ·Status: COMPLETED ·Phase: PHASE3
-
24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
NCT00551538 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs
NCT01203111 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes
NCT01880736 ·Status: COMPLETED ·Phase: PHASE3
-
Satisfaction of Treatment Among Elderly Patients With Insulin Therapy
NCT01240200 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
NCT05362058 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
NCT00135057 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control
NCT00701831 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria
NCT03862690 ·Status: WITHDRAWN
-
A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin
NCT02967224 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
NCT02787551 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
NCT01794143 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital
NCT01203774 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes
NCT01618214 ·Status: COMPLETED ·Phase: PHASE4